To determine whether complement-mediated lysis occurs in the absence of virus-specific Abs, we incubated SARS-CoV-2 with non-immune NHS (niNHS) purchased before the start of the COVID-19 pandemic (Figure S2C), followed by virus titration via TCID50 assay. This evidence concerns the gene DDX41 and COVID-19.